OmniAb, Inc. (OABIW) stock
OABIWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/309% above fair value
$0.41−0.01 (-2.38%)
Close on Oct 30, 2026Market cap $742.95MP/E –Yield –
OmniAb profit margin
Profit margin (net margin) is net income as a percentage of revenue.
OmniAb's profit margin for the twelve months ending Sep 30, 2026 was -108.1%. For fiscal 2025 it was -347.0%, against -235.1% the year before. The highest annual figure on record is -37.8% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -347.0% | −112.0 |
| FY2024 | Dec 31, 2024 | -235.1% | −86.9 |
| FY2023 | Dec 31, 2023 | -148.2% | −110.4 |
| FY2022 | Dec 31, 2022 | -37.8% | +40.0 |
| FY2021 | Dec 31, 2021 | -77.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -393.9% | +344.2 |
| Q2 FY2026 | Jun 30, 2026 | -43.7% | +363.7 |
| Q1 FY2026 | Mar 31, 2026 | -53.4% | +384.7 |
| Q4 FY2025 | Dec 31, 2025 | -169.3% | −48.3 |
| Q3 FY2025 | Sep 30, 2025 | -738.1% | −345.6 |
| Q2 FY2025 | Jun 30, 2025 | -407.4% | −228.3 |
| Q1 FY2025 | Mar 31, 2025 | -438.1% | +60.7 |
| Q4 FY2024 | Dec 31, 2024 | -121.0% | +170.5 |
| Q3 FY2024 | Sep 30, 2024 | -392.4% | −105.1 |
| Q2 FY2024 | Jun 30, 2024 | -179.0% | +33.0 |
| Q1 FY2024 | Mar 31, 2024 | -498.8% | −462.8 |
| Q4 FY2023 | Dec 31, 2023 | -291.4% | −310.7 |
| Q3 FY2023 | Sep 30, 2023 | -287.3% | −105.1 |
| Q2 FY2023 | Jun 30, 2023 | -212.0% | −69.3 |
| Q1 FY2023 | Mar 31, 2023 | -36.1% | +29.2 |
| Q4 FY2022 | Dec 31, 2022 | 19.3% | – |
| Q3 FY2022 | Sep 30, 2022 | -182.3% | – |
| Q2 FY2022 | Jun 30, 2022 | -142.7% | – |
| Q1 FY2022 | Mar 31, 2022 | -65.3% | – |